Avenue Therapeutics, Inc. (ATXI) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -438K | -854K | 383K | -176K | -1.19M | -764K | -2.89M | -2.25M | -3.12M | -2.32M | -889K | -4.67M |
| Operating CF Margin % | - | - | - | -12.54% | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 63.07% | -11.78% | 113.26% | 92.19% | 61.99% | 67.13% | -224.97% | 51.7% | -98.35% | 44.26% | -60.47% | -394.7% |
| Net Income | -695K | -720K | -698K | 329K | -1.86M | -1.56M | -3.09M | -2.7M | -4.35M | 617K | 513K | -4.01M |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 61K | 142K | 163K | 175K | 185K | 522K | 331K | 192K | 191K | 307K | 561K | 27K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 196K | -276K | 918K | -5K | 40K | 467K | -4K | 94K | 698K | -2.34M | -1.57M | 1.2M |
| Working Capital Changes | 0 | 0 | 0 | -675K | 447K | -194K | -129K | 162K | 340K | -911K | -391K | -1.88M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13K | 13K | -13K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 47K | -411K | -73K | 0 | 0 | 0 | 0 | 115K | 389K | 0 | 0 | 0 |
| Cash from Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1M | -2M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1M | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2M |
| Cash from Financing | 0 | 0 | 0 | 0 | 2.09M | 761K | 567K | 3.98M | 4.53M | 3.95M | 479K | 0 |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 0 | 0 | 0 | 2.09M | 761K | 567K | 295K | 0 | 3.87M | 550K | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.68M | 4.53M | 72K | -71K | 0 |
| Net Change in Cash | -438K | -854K | 383K | -176K | 908K | -3K | -2.32M | 1.73M | 1.41M | 1.62M | -1.41M | -6.67M |
| Free Cash Flow | -438K | -854K | 383K | -176K | -1.19M | -764K | -2.89M | -2.25M | -3.12M | -2.32M | -1.89M | -4.67M |
| FCF Margin % | - | - | - | -12.54% | - | - | - | - | - | - | - | - |
| FCF Growth % | 63.07% | -11.78% | 113.26% | 92.19% | 61.99% | 67.13% | -52.94% | 51.7% | -98.35% | 44.26% | -240.97% | -394.7% |
| FCF per Share | -0.13 | -0.27 | 0.12 | -0.06 | -0.40 | -0.48 | -1.81 | -2.02 | -5.55 | -0.09 | -0.23 | -45.10 |
| FCF Conversion (FCF/Net Income) | 0.63x | 1.20x | -0.56x | -0.53x | 0.64x | 0.49x | 0.94x | 0.31x | 0.72x | -3.63x | -1.69x | 1.16x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |